ARCHIVES

Study: Routine CT Not Needed In Detecting DLBCL Remissions

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Common Chemotherapy Fertilizes Marrow Before Tumors Take Root

May 25, 2012

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

Chabner Calls For Audit Of I-ELCAP Data, Full Financial Disclosure.

May 2, 2008

Hammer to Produce US-USSR “Cancer Summit” March 29

March 25, 1988